For ischemic stroke, SGLT2 had a neutral effect (RR = 0.99, 95% CI 0.88–1.11, P = 0.952) without any significant heterogeneity (I2 = 0%, P for interaction = 0.608; Fig. 3A). The gene discussed is SLC5A2; the disease is ischemic stroke.